Transgenic Expression of Human CD46 on Porcine Endothelium. Issue 10 (October 2015)

• Record Type: Journal Article
• Authors: Bongoni, Anjan K.; Kiermeir, David; Schnider, Jonas; Jenni, Hansjörg; Garimella, Pavan; Bähr DVM, Andrea; Klymiuk, Nikolai; Wolf, Eckhard; Ayares, David; Voegelin, Esther; Constantinescu, Mihai A.; Seebach, Jörg D; Rieben, Robert
• Is Part Of: Transplantation. Volume 99:Issue 10(2015)
• Publication Date: 2015-10
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Transplantation immunology -- Periodicals; 617.95
• DOI: 10.1097/TP.0000000000000746
• Languages: English
• ISSNs: 0041-1337

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Background</title> <p>Dysregulation of the coagulation system due to inflammatory responses and cross-species molecular incompatibilities represents a major obstacle to successful xenotransplantation. We hypothesized that complement inhibition mediated by transgenic expression of human CD46 in pigs might also regulate the coagulation and fibrinolysis cascades and tested this in ex vivo human-to-pig xenoperfusions.</p> </sec> <sec> <title>Methods</title> <p>Forelimbs of wild-type and hCD46/HLA-E double transgenic pigs were ex vivo xenoperfused for 12 hours with whole heparinized human blood. Muscle biopsies were stained for galactose-α1, 3-galactose, immunoglobulin M, immunoglobulin G, complement, fibrin, tissue factor, fibrinogen-like protein 2, tissue plasminogen activator (tPA), and plasminogen activator inhibitor (PAI)-1. The PAI-1/tPA complexes, D-dimers, and prothrombin fragment F1 + 2 were measured in plasma samples after ex vivo xenoperfusion.</p> </sec> <sec> <title>Results</title> <p>No differences of galactose expression or deposition of immunoglobulin M and immunoglobulin G were found in xenoperfused tissues of wild type and transgenic limbs. In contrast, significantly lower deposition of C5b-9 (<italic>P</italic> < 0.0001), fibrin (<italic>P</italic> = 0.009), and diminished expression of tissue factor (<italic>P</italic> = 0.005) and fibrinogen-like protein 2 (<italic>P</italic> = 0.028) were found in xenoperfused tissues of transgenic limbs. Levels of prothrombin fragment F1 + 2 (<italic>P</italic> = 0.031) and D-dimers (<italic>P</italic> = 0.044) were significantly lower in plasma samples obtained from transgenic as compared to wild-type pig limb perfusions. The expression of the fibrinolytic marker tPA was significantly higher (<italic>P</italic> = 0.009), whereas PAI-1 expression (<italic>P</italic> = 0.022) and PAI-1/tPA complexes in plasma (<italic>P</italic> = 0.015) were lower after transgenic xenoperfusion as compared to wild-type xenoperfusions.</p> </sec> <sec> <title>Conclusions</title> <p>In this human-to-pig xenoperfusion model, complement inhibition by transgenic hCD46 expression led to a significant inhibition of procoagulant and antifibrinolytic pathways.</p> </sec> </abstract>